O'Day Daniel Patrick 4

What Happened Daniel Patrick O'Day, Chairman & CEO of Gilead Sciences (GILD), sold a total of 15,000 shares in open-market transactions on June 1, 2026. The sales break down as: 10,900 shares @ $131.10 for $1,428,983; 3,062 shares @ $132.22 for $404,843; and 1,038 shares @ $132.97 for $138,021 — total proceeds ~$1,971,847. These were dispositions (sales), not purchases.

Key Details

• Date of transactions: June 1, 2026 (Form 4 filed June 2, 2026).
• Individual trades: 10,900 @ $131.10; 3,062 @ $132.22; 1,038 @ $132.97.
• Total shares sold / proceeds: 15,000 shares / ~$1.97M.
• Shares owned after transaction: not specified in the supplied filing data.
• Notable footnotes: F1 — transactions were made pursuant to a Rule 10b5-1 trading plan adopted Feb 25, 2026. F2–F4 — sale-price ranges are reported; a full breakdown by specific prices is available to the SEC, issuer, or shareholders on request.
• Timeliness: Filing was made the next day (June 2) for June 1 trades — appears timely.

Context Sales executed under a Rule 10b5-1 plan are prearranged trades and are commonly used by insiders to sell shares on a schedule. Such sales are routine disclosures of insider activity and do not, by themselves, indicate management’s view of the company’s prospects.